Bruker Launches Molecular Phenomics Research Tool for Long COVID Multi-Organ Risk Assessment
Bruker launched PhenoRisk PACS RuO, a research-use-only NMR test for molecular phenomics research on Long COVID patients’ blood samples.
Bruker launched PhenoRisk PACS RuO, a research-use-only NMR test for molecular phenomics research on Long COVID patients’ blood samples.
Some of the brightest minds in the industry shared their perspectives on the latest developments in laboratory science, along with the essentials of CLIA compliance and accreditation - and the CLP team was there to take it all in and share some highlights with you in our most recent podcast!
New research has identified specific genes which could provide vital information about the biology of developmental coordination disorder, or dyspraxia.
Researchers have revealed how variants of a gene responsible for packing and condensing genetic material present a novel cause for certain neurodevelopmental disorders.
Read MoreHear perspectives on the benefits of automation from 4 laboratorians, including a lab director, an experienced specialist, and a “next-generation” generalist. They discuss error reduction, quality control, turnaround time, and more
Read MoreResearchers developed a first-of-its-kind molecular catalog of cells in healthy lungs and the lungs of people with cystic fibrosis.
Read MoreThe OMNY Health Platform is a healthcare data-sharing solution that accelerates innovation by connecting the healthcare ecosystem with opportunities to connect anonymized data with researchers from life sciences organizations.
Read MoreResearchers found low blood levels of immune cells called lymphocytes, in combination with higher levels of inflammation on PET/CT scans, are indicators of active sarcoidosis—an inflammatory disease that attacks multiple organs, particularly the lungs and lymph nodes.
Read MoreAkershus University Hospital and Bio-Me are collaborating on a study of the long-term effects of covid-19 in adolescents and young adults, investigating the involvement of the microbiome.
Read MoreMaintaining and improving the quality of the sections produced in any histology laboratory is a challenge. Histologists need to know the key factors that determine quality and have an understanding of the theoretical basis which underlies them.
Read MoreUpdated to reflect current CLSI standards, the video places emphasis on the impact preanalytical errors have on test results and patient care.
Read MoreNew research findings offer hope that a new test could be developed to diagnose Parkinson’s through a simple and painless skin swab.
Read MoreThe pressure to deliver faster turnaround times on increased test volumes with less budget is...
Read MoreThe importance of stain workflow standardization and consistency for in-vitro diagnostics is of...
Read MoreJoin CLP Magazine and Dr. Peter Friebe, Senior Manager Clinical Application and Marketing Support at Thermo Fisher Scientific as they discuss Thermo Fisher’s complete solution to COVID-19 testing and how automation increases throughput for their partners.
Read MoreThe study suggests that such liquid biopsies could help personalize treatment for oligometastatic colorectal cancer.
Read MoreNew research has shown that results of blood tests routinely performed by GPs everywhere contain a hidden fingerprint that can identify people silently developing potentially fatal liver cirrhosis.
Read MoreJ. Craig Venter shares in Scientific American his experience mapping the human genome and his frustrations with how little progress we’ve made in putting it to use 20 years later.
Read More